MedPath
NMPA Approval

Neostigmine Methylsulfate Injection

国药准字H20254190

May 20, 2025

Drug Information

甲硫酸新斯的明注射液

注射剂

2ml:1mg

化学药品

May 20, 2025

Company Information

Applicant Company

南京经济技术开发区乌龙山路28号

Manufacturing Company

江苏省泗阳县长江路 21 号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

甲硫酸新斯的明注射液 - NMPA 批准文号 | MedPath